Figure 3.
Figure 3. Effect of age on survival outcomes for patients. (A) OS between etoposide users and nonusers among patients age <45 years old based on SNUH data. (B) PFS between etoposide users and nonusers among patients age <45 years based on SNUH data. (C) OS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (D) PFS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (E) OS between etoposide users and nonusers among patients age <45 years based on KCCR data. (F) PFS between etoposide users and nonusers among patients age <45 years based on KCCR data. (G) OS between etoposide users and nonusers among patients age ≥45 years based on KCCR data. (H) PFS between etoposide users and nonusers among patients age ≥45 years based on KCCR data.

Effect of age on survival outcomes for patients. (A) OS between etoposide users and nonusers among patients age <45 years old based on SNUH data. (B) PFS between etoposide users and nonusers among patients age <45 years based on SNUH data. (C) OS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (D) PFS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (E) OS between etoposide users and nonusers among patients age <45 years based on KCCR data. (F) PFS between etoposide users and nonusers among patients age <45 years based on KCCR data. (G) OS between etoposide users and nonusers among patients age ≥45 years based on KCCR data. (H) PFS between etoposide users and nonusers among patients age ≥45 years based on KCCR data.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal